Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCyclacel Pharmac Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Cyclacel Pharmac Earnings Date And Information
Cyclacel Pharmac last posted its earnings results on Thursday, November 13th, 2025. The company reported $-0.00052 earnings per share for the quarter, topping analysts' consensus estimates of $-72 by $71.99948. The company had revenue of 746.92 K for the quarter and had revenue of 747.00 K for the year. Cyclacel Pharmac has generated $-6 earnings per share over the last year ($-6.45 diluted earnings per share) and currently has a price-to-earnings ratio of -1.54. Cyclacel Pharmac has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Cyclacel Pharmac Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q4 2025 | N/A | $1.95 | N/A | $25.00 K | $746.92 K |
| 11/13/2025 | Q3 2025 | -$72.00 | -$1.31 | 70.69 | $25.00 K | $81 |
| 08/13/2025 | Q2 2025 | N/A | -$0.84 | N/A | $25.00 K | $0 |
| 05/14/2025 | Q1 2025 | N/A | -$6.25 | N/A | $25.00 K | $0 |
| 04/02/2025 | Q4 2024 | -$4.64 | -$0.35 | 4.29 | $10.00 K | $-35,000 |
| 11/12/2024 | Q3 2024 | -$0.54 | -$0.97 | -0.43 | $10.00 K | $10.00 K |
| 08/14/2024 | Q2 2024 | -$0.83 | -$1.93 | -1.1 | $30.00 K | $4.00 K |
| 05/14/2024 | Q1 2024 | -$4.93 | -$2.43 | 2.5 | N/A | $29.00 K |
| 03/21/2024 | Q4 2023 | N/A | -$6.23 | N/A | N/A | $31.00 K |
| 11/28/2023 | Q3 2023 | N/A | -$7.19 | N/A | N/A | $16.00 K |
| 08/10/2023 | Q2 2023 | N/A | -$6.54 | N/A | N/A | $373.00 K |
| 05/11/2023 | Q1 2023 | -$10.19 | -$6.97 | 3.22 | N/A | $0 |
| 03/08/2023 | Q4 2022 | N/A | -$8.92 | N/A | N/A | $0 |
| 11/10/2022 | Q3 2022 | N/A | -$6.24 | N/A | N/A | $0 |
| 08/11/2022 | Q2 2022 | N/A | -$6.80 | N/A | N/A | $0 |
| 05/12/2022 | Q1 2022 | N/A | -$6.20 | N/A | N/A | $0 |
| 03/30/2022 | Q4 2021 | N/A | -$8.12 | N/A | N/A | $0 |
| 11/12/2021 | Q3 2021 | N/A | -$8.03 | N/A | N/A | $0 |
| 08/12/2021 | Q2 2021 | N/A | -$8.38 | N/A | N/A | $0 |
| 05/14/2021 | Q1 2021 | N/A | -$7.39 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cyclacel Pharmac Earnings: FAQ's
In the previous quarter, Cyclacel Pharmac (:CYCC) reported $-0.00052 earnings per share (EPS) to beat the analysts' consensus estimate of $-72 by $71.99948.
The conference call for Cyclacel Pharmac's latest earnings report can be listened to online.
The conference call transcript for Cyclacel Pharmac's latest earnings report can be read online.
Cyclacel Pharmac (:CYCC) has a recorded annual revenue of $747.00 K.
Cyclacel Pharmac (:CYCC) has a recorded net income of $-2,998,000.Cyclacel Pharmac has generated $-6.45 earnings per share over the last four quarters.
Cyclacel Pharmac (:CYCC) has a price-to-earnings ratio of -1.54 and price/earnings-to-growth ratio is -0.